Marathon Trading Investment Management LLC Cardiff Oncology, Inc. Transaction History

Marathon Trading Investment Management LLC

  • $201 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
BUY
$2.22 - $5.89 $5,727 - $15,196
2,580 Added 17.2%
17,580 $39,000
Q1 2024

May 10, 2024
BUY
$1.46 - $5.91 $21,900 - $88,650
15,000 New
15,000 $80,000

Others Institutions Holding CRDF

# of Institutions
91
Shares Held
12.1M
Call Options Held
813K
Put Options Held
91.1K
View Full List

About Cardiff Oncology, Inc.

CRDF Quotes by TradingView
  • Ticker CRDF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,334,900
  • Market Cap $153M
  • Description
  • Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; meta...
More about CRDF
Track This Portfolio

Track Marathon Trading Investment Management LLC Portfolio

Follow Marathon Trading Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marathon Trading Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marathon Trading Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email